Squarepoint’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,769
| Closed | -$2.16M | – | 2985 |
|
|
2023
Q1 | $2.16M | Sell |
23,769
-65,515
| -73% | -$5.96M | 0.01% | 807 |
|
|
2022
Q4 | $3.39M | Buy |
89,284
+48,065
| +117% | +$1.83M | 0.01% | 592 |
|
|
2022
Q3 | $1.04M | Buy |
41,219
+18,044
| +78% | +$454K | 0.01% | 1065 |
|
|
2022
Q2 | $704K | Buy |
+23,175
| New | +$704K | ﹤0.01% | 1214 |
|
|
2022
Q1 | – | Sell |
-74,679
| Closed | -$1.97M | – | 2998 |
|
|
2021
Q4 | $1.97M | Buy |
74,679
+54,683
| +273% | +$1.44M | 0.01% | 874 |
|
|
2021
Q3 | $2.01M | Buy |
19,996
+13,052
| +188% | +$1.31M | 0.01% | 785 |
|
|
2021
Q2 | $983K | Sell |
6,944
-671
| -9% | -$95K | ﹤0.01% | 1186 |
|
|
2021
Q1 | $759K | Buy |
7,615
+5,112
| +204% | +$510K | ﹤0.01% | 1267 |
|
|
2020
Q4 | $309K | Buy |
+2,503
| New | +$309K | ﹤0.01% | 1840 |
|
|
2020
Q3 | – | Sell |
-6,648
| Closed | -$1.04M | – | 2784 |
|
|
2020
Q2 | $1.04M | Buy |
+6,648
| New | +$1.04M | 0.02% | 913 |
|
|
2020
Q1 | – | Sell |
-19,751
| Closed | -$4.04M | – | 2606 |
|
|
2019
Q4 | $4.04M | Buy |
19,751
+15,732
| +391% | +$3.22M | 0.02% | 561 |
|
|
2019
Q3 | $323K | Sell |
4,019
-3,481
| -46% | -$280K | ﹤0.01% | 1778 |
|
|
2019
Q2 | $708K | Sell |
7,500
-2,080
| -22% | -$196K | 0.01% | 1437 |
|
|
2019
Q1 | $819K | Sell |
9,580
-11,025
| -54% | -$943K | 0.01% | 1190 |
|
|
2018
Q4 | $1.16M | Buy |
20,605
+8,155
| +66% | +$458K | 0.01% | 854 |
|
|
2018
Q3 | $1.02M | Buy |
+12,450
| New | +$1.02M | 0.01% | 977 |
|
|
2018
Q2 | – | Sell |
-33,000
| Closed | -$677K | – | 2127 |
|
|
2018
Q1 | $677K | Buy |
33,000
+17,566
| +114% | +$360K | 0.01% | 966 |
|
|
2017
Q4 | $437K | Buy |
+15,434
| New | +$437K | 0.01% | 1282 |
|